Bullseye Asset Management LLC Liquidia Corp Transaction History

Bullseye Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.34 - $8.28 $320,183 - $610,857	-73,775 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$4.86 - $11.44 $85,438 - $201,115	17,580 Added 31.28%	73,775 $621,000
Q1 2020 May 08, 2020	SELL	$3.31 - $7.15 $791 - $1,708	-239 Reduced 0.42%	56,195 $265,000
Q4 2019 Feb 18, 2020	BUY	$3.07 - $5.11 $173,252 - $288,377	56,434 New	56,434 $241,000

157

35.5M

1.68M

1.17M

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $787M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bullseye Asset Management LLC with notifications on news.